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Abstract  
AIM: The aim of this study was to analyze the cytotoxicity of ciprofloxacin (CIP) loaded on chitosan 
bioactive glass scaffold on human periodontal ligament stem cells (PLSCs) in vitro. 
MATERIALS AND METHODS: PLSCs obtained from human third molars, cultures treated with 
medium containing 15 x 15 mm chitosan/bioactive glass scaffolds without/with different 
concentration 0, 5, 10, and 20 % of CIP. A total of 15 x 10^3 cells were plated in 6 well plates. The 
attached cells of each group were harvested from the plates after 1, 4 and 8 days of culture to 
detect the viability of cells. The cell number was determined using a hemocytometer and the trypan 
blue dye-exclusion assay. Data was analyzed using normality using Shapiro-Wilk test. 
Comparisons between groups were made using One-way ANOVA complemented by Tukey's test. 
RESULTS: When comparing the proliferation rate of cells in the four groups, no statistically 
significant difference was found (P = 0.633). With regards to cell viability, no statistical difference 
was found between the 0, 5, and 10 % CIP concentrations, while the 20 % CIP concentration 
demonstrated the least viability with a high statistically significant difference (P = 0.003). 
CONCLUSION: Twenty percentages CIP demonstrated the least proliferation rate and viability. 
 
 
 
 
 
 
 
Introduction 
 
Periodontitis is a complex disease which 
occurs when environmental and bacterial factors with 
allelic variants of multiple genes act synergistically to 
increase or decrease the likelihood of developing a 
disease [1]. Dental pathogens are not planktonic but 
form complex communities called biofilms that cause 
chronic infections by resisting antibiotic treatments 
and killing by the host immune system [2]. 
Aggressive periodontitis (AgP) is a type of 
periodontal diseases that causes rapid destruction of 
the periodontal attachment apparatus and the 
supporting alveolar bone. The familial nature of AgP 
has led to speculation that a major gene defect is 
responsible for its transmission and many genetic 
disorders are associated with AgP such as Papillon 
Lefevre syndrome and Down syndrome [1]. Patients 
with AgP often present with limited microbial deposits 
that seem inconsistent with the severity of tissue 
destruction but often have elevated levels of 
Aggregatibacter actinomycetemcomitans (Aa), that 
possess variety of virulence factors that can impair 
PMNL's function and potentiate the disease process 
[3] and does not respond to mechanical therapy alone 
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as these pathogens have been found to be invasive 
and re-infect the pocket. Thus, augmenting 
mechanical therapy with antibiotics should be used to 
eliminate the pathogens left in the tissues [4]. 
Many clinical studies and systematic reviews 
have attested to the beneficial effects of using 
systemic as well as local antibiotics as an adjunctive 
therapy to mechanical scaling and root planning in 
terms of pocket reduction and attachment gain, and 
these effects are more pronounced in AgP patients. 
However, it has been reported that the benefits of 
systemic antibiotics administrated in periodontal 
therapy should be balanced against the possible side 
effects of the repeated use of these antibiotics in 
treating periodontal diseases, and that in comparison 
to systemic antibiotics, the application of 
antimicrobials by sustained-delivery devices may offer 
a better pocket depth reduction and gain in 
attachment level without the side effects seen in 
systemic antibiotics [5]. 
It has been found that both systemic 
antibiotics and topical chlorhexidine in patients with 
AgP did not reduce the percentage of invaded 
epithelial cells, which points out the fact that 
intracellular reservoirs of bacteria exist and may lead 
to disease recurrence and/or refractory treatment in 
these patients. This invasion might cause the bacteria 
to withstand systemic antibiotic treatment [6].  
Porous three-dimensional scaffolds have the 
ability to attach to cells and allow their proliferation [7]. 
Chitosan (C), a deacetylation derivative of chitin has 
gained much attention as a functional material for 
biomedical applications due to its non-antigenicity, 
biocompatibility and the ability to support cell 
attachment and proliferation [7]. It is a potential 
candidate for targeting antibiotic resistant 
microorganism due to a broad spectrum of 
antimicrobial activity [8]. Bioactive glasses (G) are 
ideal candidates for regeneration and the 
incorporation of these glasses into a chitosan scaffold 
have been shown to provide a backbone for the 
scaffold [9]. Ciprofloxacin (CIP), a fluoroquinone is 
more effective against gram-negative bacteria, 
particularly Aa [10]. It is the only antibiotic used in 
periodontal therapy to which all strains of Aa are 
susceptible [11]. CIP level in the gingival crevicular 
fluid was also demonstrated to be significantly higher 
than in serum [12]. Antibiotics loaded on scaffolds and 
released into the periodontal pocket should not be 
toxic to the living cells [13]. Cells from the pulp and 
apical papilla were shown to be susceptible to CIP 
toxic effects. These effects also depend on the 
dosage and time of exposure of these cells to CIP [12, 
13].  
The purpose of this study was to evaluate the 
cytotoxic effect of different concentration of CIP 
loaded on a chitosan/glass scaffold on the 
proliferation and viability of PLSCs.  
Materials and Methods 
 
Fabrication of scaffold 
Tetraethyl orthosilicate (TEOS: Fluka, wt = 
208.33), calcium nitrate hydrate (Fluka, M.wt = 236), 
sodium hydroxide (Prolab, M.wt = 40) and ammonium 
dihydrogenphosphate (MERK, M. wt = 115.03) in 
addition with chitosan of medium molecular weight 
were used in this study. The 46S6 bioactive glass with 
the composition (46% SiO2, 24% CaO, 24% Na2O, 6% 
P2O5wt%) was prepared by sol-gel technique and 
named (S) [16]. A mixture of chitosan (C) in a 
concentration of 3% w/vand the previously prepared 
bioactive glass (G) of the ratio 1:2 was used in this 
study. CIP in different ratios: 0, 5, 10 and 20 wt% 
were added to the above formula during preparation 
and named; CIP- 0%, CIP -5%, CIP -10% and CIP -
20%, respectively. The freeze drying technique was 
used to get porous scaffolds. The composition of all 
the prepared scaffold formulations was cast in a 
mould with dimensions1.2 x 0.3 cm, kept at -80
o
C for 
overnight, and freeze dried at the same temperature 
for 24 h before further cell culture analysis [15,16].  
 
Characterization 
Scaffold morphology by SEM 
Scanning electron microscope (SEM) coupled with 
energy dispersive spectroscopy (EDS) was used for 
morphological evaluation and elemental analysis. 
SEM analyses were performed on the structure of the 
drug and the surface of scaffolds without/with CIP.  
 
Ciprofloxacin releases from the investigated 
scaffolds 
Phosphate buffer saline (PBS) with pH 7.4 at 
37
⁰
C was used to investigate the CIP release from the 
scaffolds. The scaffolds were immersed in 10 ml PBS 
and shacked by an incubator shaker at 100 struck per 
minute. Samples were removed at different time 
intervals and the drug concentration was determined 
using spectrophotometer at 277 nm [19]. 
 
Sampling and Cell Culture  
Healthy two lower right impacted molars, (as it 
is the latest erupted teeth and has the youngest cells), 
were extracted a traumatically, (to avoid loss of 
periodontal ligament during the extraction procedure), 
from two different healthy female patients, aged from 
18-25 years. The teeth were extracted for patients 
attending the Clinic of the Oral and Maxillofacial 
Surgery Department, National Research Centre, 
Egypt and informed consent was obtained from the 
patients before extraction. The extracted teeth were 
immediately put in a sterile 50 ml polypropylene tube 
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supplemented with culture media (DMEM) (Lonza 
Bioproducts, Belgium). Then, the teeth were 
transported to the cell culture laboratory in about 20 
minutes.  
With totally aseptic conditions, the periodontal 
ligament tissue was minced into pieces and digested 
in a solution of 2 mg/ml Collagenase NB 4 (SERVA, 
crescent chemical company, USA) for 30 minutes at 
37°C in a water bath. Single cell suspension was 
seeded into a T-25 flask (Costar, Cambridge, USA) 
with DMEM supplemented with 10% fetal bovine 
serum (FBS) (Equitech-Bio Inc., Kerrville, USA), 100 
U/ml penicillin, 100 µg/ml streptomycin and 1% 
Fungizone (Lonza Bioproducts, Belgium), then 
incubated in 5% carbon dioxide incubator at 37°C. 
The samples were sub-cultured after reaching 80-85% 
confluence by utilizing 0.25% trypsin and 0.02% 
EDTA to get the next passage of cells. The third and 
fourth passages were used in all the coming 
procedures. 
 
Detection of the self-renewal capability of 
PLSCs 
For this assay, 100,000 cells counted by 
hemocytometer were plated on a T-25 flask and 
incubated for 10 days. Subsequently, the cultures 
were fixed with 4% paraformaldehyde and afterward 
stained with 0.1% toluidine blue. Aggregates superior 
to or equivalent to 50 cells were scored as colonies 
[20]. 
 
Identification of PLSCs by 
immunocytofluorescence 
PLSCs were sub-cultured into 24- well cell 
culture plates, just as cells attained semi-confluency 
they were fixed with 4% paraformaldehyde for 30 min, 
afterward blocked with PBS containing 10% goat 
serum at room temperature for 30 min, and then 
incubated with primary antibody (Anti-STRO-1, mouse 
monoclonal IgM anti-human STRO- 1) (Millipore, 
Darmstadt, Germany) at dilution 1 μl: 200 μl of PBS 
for overnight at 4°C. Following washing, the samples 
were incubated with fluorescein- conjugated 
secondary antibody (goat anti-mouse IgM) for 60 
minutes in the dark. Regarding nuclei staining, DAPI 
(4, 6-diamino-2-phenylindol) was used for five 
minutes. Following washing with PBS, the samples 
were examined by fluorescence microscopy with 40 X 
original magnification [21]. 
 
Multilineage differentiation 
For osteogenic differentiation in vitro, PLSCs 
cultures were supplemented with 0.01 µmol/L 
dexamethasone, and 1.8 mmol/L inorganic 
phosphates (Sigma-Aldrich, United States). The 
medium was changed twice weekly. After that, the 
samples were stained after 14 days by 2% alizarin red 
stain to detect calcium accumulation in vitro [22]. For 
adipogenic differentiation in vitro, PLSCs cultures 
were supplemented with 0·5 μmol/L 
isobutylmethylxanthine, 0·5 μmol/L hydrocortisone, 60 
μmol/L indomethacin and 10 μg ml insulin (Sigma-
Aldrich, United States) for 21 days to induce 
adipogenic differentiation, then Oil red O staining was 
applied to identify lipid-laden fat cells [21]. 
 
Cytotoxic analysis of scaffold-CIP on 
cultured human PLSCs. 
The scaffolds (15x15 mm) were first sterilized 
by UV radiation of the laminar flow (30 min for each 
side), followed by 30 min immersion in 70 % ethanol 
[23]. A total of 15 x 10
3 
cells were plated in 6 well 
plates, after 24 hours of culture, the culture medium 
was changed. Afterward, chitosan bioglass loaded 
with different ciprofloxacin concentrations (5, 10, and 
20%) and 0 % (positive control) was added. After 1, 4 
and 8 days of culture, the cells were harvested and 
the cell number was determined by counting the 
viable cells by a hemocytometer using the trypan blue 
dye-exclusion assay, where 100 micro liter of trypan 
blue was mixed to 100 micro liter of treated cellular 
suspension and left for 10 minutes, then 10 μl of the 
mixture was spread into both chambers of the 
hemocytometer. Subsequently, the hemacytometer 
was observed under an inverted light microscope 
using the 20 x objective lens. The number of viable 
cells harvested was obtained by the following 
equation: UC×D×104/nSQ, where UC is the unstained 
cell count (viable cells), D is the dilution of the cell 
suspension, and nSQ is the number of counted 
squares in the hemocytometer. Viable cells appear 
colorless and bright under phase contrast microscopy. 
Nonviable cells appear blue-stained and are non-
refractile. The viable percentage of the cell population 
was obtained using the equation: UC/TC× 100, where 
UC is the unstained cell count (viable cells) and TC is 
the total cell count (stained plus unstained cells) [24]. 
 
Statistical Analysis 
Analysis of data was performed utilizing 
SPSS 18 (Statistical Package for Scientific Studies) 
for Windows. Data were explored for normality using 
Shapiro-Wilk test. Comparisons between groups were 
made utilizing One-way ANOVA complemented by 
Tukey's test. The level of significance was p < 0.05. 
 
 
Results 
Representative SEM micrographs of the 
synthesized scaffolds (CIP-0%) are presented in (Fig. 
1), where it can be noticed that the addition of (G) to 
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the (C) scaffold gave a homogeneous structure of the 
scaffold with a rough texture compared to the smooth 
structure of a previously prepared chitosan scaffold 
alone. The mean pore diameter of the prepared 
scaffolds ranged between 40-60 µm, pointing to the 
wide range of interconnected pores of the scaffolds 
which can facilitate cell migration, adhesion, and 
proliferation.  
 
Figure 1: Scanning Electron Micrograph of scaffold without 
ciprofloxacin (CIP-0%), the glass particles homogeneously 
distributed as in (A) and the porosity are in the range of 40-60 µm 
(B), magnification 300 µm and 500 µm, respectively 
 
The SEM micrographs and the elemental 
analyses of the CIP drug denoted in Fig. 2A,B, while 
the prepared scaffold loaded with (CIP-20%) 
presented in Fig. 2 C, D. The rod shape of the drug 
could be seen, where the elemental analysis proved 
the presence of carbon (C) and oxygen (O) of the 
drug.  
 
Figure 2: SEM micrographs and EDS of: the drug ciprofloxacin, CIP 
(A, B) with magnification 100µm, rod shape of the drug (A) 
elements of C and O appears in (B) and for chitosan/ bioactive 
glass scaffold loaded with  CIP-20% (C,D) with magnification 1 µm, 
the glass crystals appear and the rod shape of the drug embedded 
in the chitosan matrix (C) and the elements of Ca, Na, Si and P of 
the glass beside that of the drug C and O (D) 
 
However, addition of the glass in the scaffold 
was confirmed by the presence of silicon (Si), 
phosphorous (P), sodium (Na) and calcium (Ca) in 
addition to (C) and (O) of the drug, which indicates the 
homogenous incorporation of the glass in the 
structure of the scaffold. CIP concentrations above 5 
wt% led to the formation of fibers with significantly 
smaller diameters than PDS (p < 0.001).  
In our assay, it is obvious that the drug 
release increased with increasing the drug 
concentration (from 5, 10 and 20 %). This is attributed 
to the difference between the concentration of the 
drug in the scaffold and that in the surrounding media, 
which could be explained by the large driving force of 
the drug release. 
 
Cell culture 
PLSCs were successfully isolated from 
extracted impacted teeth. By observation of PLSCs 
under inverted microscopy, they appeared as 
fibroblast-like shaped cells after 3 days of culturing, 
which are characteristic to PLSCs. The cultured cells 
were rapidly proliferated till became confluent about 
80%-90% after 7 days of culturing.  
 
Colony forming unit-fibroblast (CFU-F) 
assay 
PDLSCs possess the potential to form 
clonogenic cell clusters, detected by the development 
of about 120 colonies, engendered from 100,000 
single cells after culturing at low density, suggesting 
the large proliferative capacity for PLSCs. The cells 
within each colony were defined with a fibroblast-like 
morphology as revealed in (Fig. 3A). 
 
Immunocytofluorescence 
Indirect immunocytofluorescence technique 
was utilized to identify STRO 1 antigen. In the current 
research, PDLSCs that was isolated were discovered 
to express the mesenchymal stem-cell marker STRO -
1 as demonstrated in (Fig. 3B). 
 
Multilineage differentiation 
On behalf of the osteogenic potential of 
PLSCs, our findings revealed that isolated PDLSCs 
revealed positive staining for calcium accumulation in 
vitro by utilizing Alizarin red stain after 14 days of 
culturing in osteogenic media (Fig. 3C). In addition, for 
the adipogenic potential of PLSCs, our results 
presented that PLSCs expressed oil red O-positive 
lipid clusters after 21 days of induction (Fig. 3D). 
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Figure 3: (A) Phase contrast micrograph showing a colony formed 
by PDLSCs after staining by toluidine blue stain. (4X). (B) Phase 
contrast micrograph showing PDLSCs express the MSC marker 
STRO-1 (Green colour). Notice counter stain of the nuclei by DAPI 
(Blue colour). (Indirect immunocytofluorescence, 40X). (C) Phase 
contrast micrograph showing extracellular calcium accumulation 
(Orange - red nodules) by differentiated PLSCs after 14 days of 
osteogenic induction (Alizarin red stain, 4X), and (D) Fat droplets 
formed by PLSCs after 21 days of adipogenic induction (oil red O 
stain, 40X). Phase contrast micrograph showing PLSCs after 8 
days of culturing with scaffold loaded with (E) 0% Cipro, (F) 5% 
Cipro, (G) 10% Cipro and (H) 20% Cipro, maintained their PLSCs 
morphological characteristics 
 
Cytotoxic analysis of scaffold-CIP on 
cultured human PLSCs 
Results are summarized in Tables 1 & 2. 
PLSCs after 8 days of culturing with CIP with different 
concentrations retained their PLSCs morphological 
characteristics compared to control untreated cells as 
shown in Fig. 3 E,F,G,H. After 24-hour time period, 
CIP 0%, CIP 5%, CIP 10% resulted in cell proliferation 
rates of 85×10
3
, 65×10
3
, 55×10
3
, respectively and 
viabilities of 100 % in all three groups, while the CIP 
group of 20 % concentration resulted in cell 
proliferation rate of 50 ×10
3 
and viability of 98 %. After 
4 days, the cell proliferation rates of the CIP 0%, CIP 
5%, CIP 10% and CIP 20% ciprofloxacin groups 
resulted in 180×10
3
, 120×10
3
, 90×10
3
 and 80 ×10
3
 
respectively, while the cell viabilities were 100% in the 
CIP 0% and CIP 5% concentration and 99 and 98 % 
in the CIP 10 % and CIP 20 % concentration groups, 
respectively. At the 8
th
 day, the CIP 0%, CIP 5%, CIP 
10% and CIP %20 concentration groups showed 
variable cell proliferation rates of 295×10
3
, 245×10
3
, 
180×10
3
, and 165×10
3
, respectively. The cell viability 
remained 100% in the CIP 0% and CIP 5% 
concentration, and also remained at 99 % for the third 
group CIP 10% at 99%, while it showed the least 
viability in the CIP 20 % group at 96%.  
Table 1: The cell proliferation rate for tested scaffolds at 
different time intervals 
Group Day 1 Day 4 Day 8 P-value 
CIP- 0% 85 x 103 180 x 103 295 x 103 
0.633 CIP- 5% 65 x 10
3
 120 x 10
3
 245x 10
3
 
CIP- 10% 55 x 103 90 x 103 180 x 103 
CIP- 20% 50 x 103 80 x 103 165x 103 
 
When comparing the proliferation rate of cells 
between the four concentrations groups, no statistical 
significance difference was found (P = 0.633). With 
regards to cell viability, no statistical difference was 
found between the 0, 5, and 10 % CIP concentrations, 
while the 20 % CIP concentration demonstrated the 
least viability with a high statistical difference (P = 
0.003). 
Table 2: Cell viability for tested scaffolds at different time 
intervals 
  Cell viability at:   
Group Day 1 Day 4 Day 8 P-value 
CIP- 0%
a 100% 100% 100% 
0.633 CIP- 5%
a 100% 100% 100% 
CIP- 10%
a 100% 99% 99% 
CIP- 20%
b 98% 98% 96% 
The same superscript letters indicate statistically non-significant values (p > 0.05). 
 
 
Discussion 
Aggressive periodontal diseases are caused 
by particular groups of microorganisms as A.a which 
is not eliminated by mechanical means alone due to 
the bacterial invasion, accordingly, adjunct anti-
infective therapy is recommended. Periodontal 
disease treatment necessitates an anti-infective agent 
to infection sites and sustaining its localized 
concentration at effective levels for a sufficient time 
whereas at the same time evoking minimal or no side 
effects [25].  
Unfortunately, the regular systemic antibiotic 
protocol for the treatment of AgP was found to be not 
effective in eradicating bacteria that reside within the 
epithelial cells. Although such treatment resulted in a 
reduction of bacteria and improved the clinical 
parameters, the number of invaded epithelial cells 
was not reduced [6]. Thus, local antibiotics are 
proposed compared to systemic antibiotics in terms of 
providing adequate dose and time to eradicate the 
infection and, also, prevent relapse without the side 
effects [26].  
The use of drug delivery systems containing 
antimicrobial agents is advocated as it aims for 
releasing a sufficient level of the drug directly inside 
the periodontal pocket. Moreover, increasing the 
exposure of target microorganisms to higher 
concentrations could be realizing, thus minimizing the 
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side effects associated with systemic drug 
administration. This, also, helps in patients where 
there is an intolerance to systemic administration and 
serves as a treatment option for localized areas of 
exudation and deep pockets not responding well to 
mechanical and systemic antibiotics [23, 24].  
The use of antibiotic-loaded scaffold 
combined with bioactive glass as targeting drug-
delivery systems for treatment of AP may allow the 
release of the drug directly into the periodontal pocket 
thus minimizes undesirable side effects caused by 
systemic drug administration and may also enhance 
patient compliance. However, these drugs should not 
exert any toxic effect on the underlying tissue. 
Therefore, this study aimed at evaluating the cytotoxic 
effects of different concentration of CIP on the viability 
and rate of proliferation of PDL stem cells. CIP was 
selected in the present study because, at present, it is 
the only antibiotic in periodontal therapy to which all 
strains of A.a. are susceptible. Previous results 
suggested that exposure of periodontal surfaces to 
CIP reduced the micro-colony size and cell surface 
density of A.a in the biofilm. Moreover, A.a resistance 
to CIP is rare or non-existent. It was also suggested 
that CIP retained bactericidal activity inside PMNs 
ultimately contributed to the enhanced intracellular 
killing of susceptible bacteria [10].  
The appropriate scaffold fabrication technique 
is a critical choice as it can significantly influence the 
scaffold properties and its degradation rate [29]. In a 
former study fibroblasts attached successfully to 
chitosan proving that it is not only a biocompatible but 
also a successful tissue engineering scaffold [30]. In 
the present study, a chitosan/glass scaffold loaded 
with different concentration of CIP was formulated 
using the freeze-drying technique. This technique 
provides a convenient and easy mean for formulating 
highly porous scaffold, with interconnected pores, that 
has the ability to enhance regeneration. The bioactive 
glass was incorporated into the chitosan scaffold to 
adjust the quality of pores, the mechanical strength 
and degradation rate of chitosan scaffolds through 
[31].  
In vitro testing using primary cells, as stem 
cells, to test the cytotoxicity of dental materials is 
more preferable than using established cell lines as 
these cells have been cultured for the first time, and 
are therefore similar to their original tissue. They are 
characterized by their largely unchanged metabolic 
status, and a high degree of differentiation [24]. 
PLSCs were used as target cells in the present study 
because they are easily accessible and are able to 
differentiate into other types of dental cells [32]. In the 
present study, CFU-F assay realized the successful 
self-renewal capacity of PLSCs from the primary cell 
culture, as well as indirect immunocytofluorescence,  
revealed that PLSCs are stained positive for the early 
MSC marker (STRO-1). Additionally, multilineage 
differentiation (osteogenic and adipogenic) of PLSCs 
was emphasized. The osteogenic potentiality was 
detected by orange – red nodules of calcium 
accumulation in vitro using alizarin red satin after 14 
days of induction. The adipogenic potentiality of 
PLSCs was shown through their positive lipid clusters 
after 21 days of induction. These findings 
demonstrated that isolated periodontal ligament cells 
fulfill the criteria of mesenchymal stem cells. Our 
results are in agreement with other investigators [17, 
18]. The trypan blue exclusion staining technique was 
chosen to differentiate nonviable from viable cells as it 
is a preferred assay due to its quickness and ease of 
performance [24].  
It was found that the process of drug release 
increased when the concentration of CIP increased 
from 5 to 20 % which was related to the increase in 
the concentration gradient between the drug in the 
scaffold and the surrounding medium. Dental cells 
were found to be susceptible to the toxic effects of 
CIP in terms of time and dosage, where decreasing 
drug concentrations and time of exposure may 
significantly improve stem cell viability [14]. In the 
present study high concentration of CIP (20%) 
decreased growth rate and viability of PLSCs. In a 
former study, 10 and 20 mg/ml concentration of CIP 
significantly reduced the rate of growth of human 
embryonic stem cells but did not affect their viability 
and differentiation characteristics. The cytotoxic effect 
of CIP was however reversed when the antibiotic was 
withdrawn and the cells regained their normal growth 
rate [13]. Also, previous data demonstrated that high 
concentrations of antibiotics are harmful to the 
survival of stem cells of the apical papilla and that it is 
important that when using bactericidal medications 
they should not have a detrimental effect on the stem 
cell viability [15].  
In conclusion, based on the results of this 
study we suggest that 5% CIP concentration might be 
a suitable concentration because it was less toxic to 
the cells than other concentrations. Our results, 
however, are preliminary and require further 
preclinical and in vivo research, to confirm the safety 
and effectiveness of this drug and ensure that its 
biological activity is retained in the delivery system. 
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